Wordt geladen...
New agent to treat advanced or metastasized thyroid cancer, its efficacy, safety, and mechanism
BACKGROUND: Vandetanib is the first US Food and Drug Administration approved agent to treat advanced or metastasized thyroid cancer. To gain a better understanding of the drug, we conducted a systematic review of its efficacy and safety in patients with thyroid cancers. METHODS: Trial data was retri...
Bewaard in:
| Gepubliceerd in: | Thorac Cancer |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4511335/ https://ncbi.nlm.nih.gov/pubmed/26273412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12238 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|